Fabian Tenenbaum
Overview
Fabian Tenenbaum received an average of $1M in total compensation, including $377K in salary, at Bellerophon Therapeutics from 2016 to 2019.
Source: SEC filings on April 23, 2020, March 28, 2019, April 5, 2018, and March 20, 2017.
Related executives
We found seven more executives who work or worked at Bellerophon Therapeutics.
Peter Fernandes
Bellerophon Therapeutics
Chief Regulatory and Safety Officer
Assaf Korner
Bellerophon Therapeutics
Chief Financial Officer
Deborah Quinn
Bellerophon Therapeutics
Chief Medical Officer
Jonathan Peacock
Bellerophon Therapeutics
Chief Executive Officer
Martin Meglasson
Bellerophon Therapeutics
Chief Scientific Officer
Reinilde Heyrman
Bellerophon Therapeutics
former Chief Clinical Development Officer
Martin Dekker
Bellerophon Therapeutics